| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99457a7f56ff09431be244053df6f67e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e8d2afa63dbd8bbb90545722d3f54c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ef8822c753a411b0e4af94da7fb5d53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91384a75cdf64fe3bf42e44c6057545d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c1c5f9713033a7cae2cdd31f0f62b62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd8cc70c28a0c00cec9c3a7ed0e03313 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10332 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-861 |
| filingDate |
2011-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bfd072df76aca92a8ac392b7d8a16f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34360db5fe3acb6ea111342b96b641b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c7d6dab07a36f2c0e77ed3c43cdcb10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e30baaf41a01c460b08eac738f6b4ac1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c05b9d94afcb5ca75a320d79d35cba3 |
| publicationDate |
2011-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011112057-A2 |
| titleOfInvention |
Novel conditionally replication-competent adenovirus and a method for producing the same |
| abstract |
The present invention relates to a conditionally replication-competent adenovirus used in the prophylaxis or treatment of a cancerous disease of a novel type, and more specifically relates to: a conditionally replication-competent adenovirus used in the prophylaxis or treatment of a cancerous disease, comprising a target-specific promoter and adenovirus genes lacking a region of all parts or some parts of E4 orf 1, 2, 3 and 4; a host cell into which the conditionally replication-competent adenovirus has been introduced; a method for producing the conditionally replication-competent adenovirus; a composition for the prophylaxis or treatment of a cancerous disease, comprising the conditionally replication-competent adenovirus; a method for the prophylaxis or treatment of a cancerous disease, comprising the step of administering the composition to an individual; and a use for the conditionally replication-competent adenovirus in the prophylaxis or treatment of a cancerous disease. |
| priorityDate |
2010-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |